candesartan cilexetil has been researched along with Obesity in 2 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated whether pharmacologic treatment of prehypertension prevents or postpones stage 1 hypertension." | 2.72 | Feasibility of treating prehypertension with an angiotensin-receptor blocker. ( Black, HR; Egan, BM; Grimm, RH; Julius, S; Kaciroti, N; Messerli, FH; Michelson, EL; Nesbitt, SD; Oparil, S; Schork, MA; Weber, MA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Julius, S | 1 |
| Nesbitt, SD | 1 |
| Egan, BM | 1 |
| Weber, MA | 1 |
| Michelson, EL | 1 |
| Kaciroti, N | 1 |
| Black, HR | 1 |
| Grimm, RH | 1 |
| Messerli, FH | 1 |
| Oparil, S | 1 |
| Schork, MA | 1 |
| Mann, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Multicenter, Long-term Trial of Preventing Hypertension Using Candesartan Cilexetil 16 mg in Patients With High Normal Blood Pressure (TROPHY)[NCT00227318] | Phase 3 | 1,000 participants | Interventional | 1998-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for candesartan cilexetil and Obesity
| Article | Year |
|---|---|
Feasibility of treating prehypertension with an angiotensin-receptor blocker.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphe | 2006 |
1 other study available for candesartan cilexetil and Obesity
| Article | Year |
|---|---|
[Treatment of high-normal blood pressure with angiotensin receptor blockers. TROPHY Study (Trial of Preventing Hypertension)].
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphe | 2007 |